Cytomos secures £1.6m additional seed funding led by Archangels
Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £1.6m funding to progress the development and qualification of its novel cell analysis platform, Cytomos Dielectric Spectroscopy (CDS). The fundraising round by Cytomos was led by existing investor Archangels with participation from